Company profile
International Vaccine Institute (IVI)
We discover, develop, and deliver safe, effective, and affordable vaccines for global health.
- Industry
- Non-profit Organizations
- Employees
- 364
- Headquarters
- Seoul
- Founded
- 1997
- Office locations
- 5
International Vaccine Institute (IVI) company summary
International Vaccine Institute (IVI) is a company in the Non-profit Organizations industry, headquartered in Seoul, founded in 1997. On LinkedIn the company has around 364 employees. The company lists 5 office locations. Its listed specialties include vaccine discovery, vaccine development, vaccine delivery, epidemiology, capacity-building.
What technology does International Vaccine Institute (IVI) use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About International Vaccine Institute (IVI)
The International Vaccine Institute (IVI) is an independent international organization originally established at the initiative of the United Nations Development Programme in 1997. Its mission is to discover, develop, and deliver safe, effective, and affordable vaccines—empowering vaccine equity, impact, and sustainability globally. IVI’s current portfolio includes vaccines in multiple stages of pre-clinical and clinical development targeting infectious diseases that significantly impact low- and middle-income countries, including cholera, typhoid fever, chikungunya, shigellosis, salmonellosis, schistosomiasis, hepatitis E, HPV- and group A strep-related diseases, and COVID-19. IVI developed the world’s first low-cost oral cholera vaccine and a new-generation typhoid conjugate vaccine, both pre-qualified by the World Health Organization (WHO). IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, an Africa Regional Office in Rwanda, a Country Office in Austria, and a Country and Project Office in Kenya. IVI additionally co-founded the Hong Kong Jockey Club Global Health Institute in Hong Kong and hosts Collaborating Centers in Bhutan, Burkina Faso, Ghana, Ethiopia, Nepal, and Madagascar. 43 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, India, Finland, Austria, and Thailand provide state funding. For more information, please visit https://www.ivi.int.
Specialties
Where is International Vaccine Institute (IVI) located?
International Vaccine Institute (IVI) lists 5 office locations.
Compare companies similar to International Vaccine Institute (IVI)
More companies in Non-profit Organizations.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
International Vaccine Institute (IVI) ivi.int | Non-profit Organizations | 364 | 1997 | Seoul |
 TED Conferences ted.com | Non-profit Organizations | 16,129 | - | New York, NY |
 UNICEF unicef.org | Non-profit Organizations | 49,147 | 1946 | New York, New York |
 World Economic Forum weforum.org | Non-profit Organizations | 5,649 | - | Cologny, Geneva |
 The Female Lead thefemalelead.com | Non-profit Organizations | 354 | - | London, England |
 World Action Careers campuslifestyle.org | Non-profit Organizations | 438 | - | harare, Mashonaland Central |
 World Food Programme wfp.org | Non-profit Organizations | 22,572 | - | Roma, RM |
 FAO fao.org | Non-profit Organizations | 20,798 | 1945 | Rome, Lazio |
 Save the Children International savethechildren.net | Non-profit Organizations | 17,378 | 1919 | London, England |
 Gates Foundation gatesfoundation.org | Non-profit Organizations | 4,204 | - | Seattle, WA |
| Non-profit Organizations | 13,759 | 1863 | Geneva, Geneva |
Frequently asked questions about International Vaccine Institute (IVI)
What does International Vaccine Institute (IVI) do?
The International Vaccine Institute (IVI) is an independent international organization originally established at the initiative of the United Nations Development Programme in 1997. Its mission is to discover, develop, and deliver safe, effective, and affordable vaccines—empowering vaccine equity, impact, and sustainability globally. IVI’s current portfolio includes vaccines in multiple stages of pre-clinical and clinical development targeting infectious diseases that significantly impact low- and middle-income countries, including cholera, typhoid fever, chikungunya, shigellosis, salmonellosis, schistosomiasis, hepatitis E, HPV- and group A strep-related diseases, and COVID-19. IVI developed the world’s first low-cost oral cholera vaccine and a new-generation typhoid conjugate vaccine, both pre-qualified by the World Health Organization (WHO). IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, an Africa Regional Office in Rwanda, a Country Office in Austria, and a Country and Project Office in Kenya. IVI additionally co-founded the Hong Kong Jockey Club Global Health Institute in Hong Kong and hosts Collaborating Centers in Bhutan, Burkina Faso, Ghana, Ethiopia, Nepal, and Madagascar. 43 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, India, Finland, Austria, and Thailand provide state funding. For more information, please visit https://www.ivi.int.
How many employees does International Vaccine Institute (IVI) have?
International Vaccine Institute (IVI) has around 364 employees on LinkedIn.
Where is International Vaccine Institute (IVI) headquartered?
International Vaccine Institute (IVI) is headquartered in Seoul.
Where does International Vaccine Institute (IVI) have offices?
International Vaccine Institute (IVI) lists 5 office locations, including Seoul, 08826, KR; Kigali, RW, RW; Nairobi, KE, KE; Stockholm, SE, SE; Vienna, AT, AT.
When was International Vaccine Institute (IVI) founded?
International Vaccine Institute (IVI) was founded in 1997.
Build a lead list from companies like International Vaccine Institute (IVI)
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.